Publication of the final Ockenden Report into Shrewsbury and Telford Hospital NHS Trust

Post by: Charley Turton Today the Ockenden report into failings in maternity care at the Shrewsbury and Telford Hospital NHS Trust has been published. Vanessa Cashman of 12KBW’s clinical negligence team will bring you a blog post offering analysis of the report in the coming weeks. For those of you who cannot wait that long, … Continue reading Publication of the final Ockenden Report into Shrewsbury and Telford Hospital NHS Trust

The criminal prosecution of East Kent Hospitals University NHS Foundation Trust for the unsafe clinical care leading to the death of baby Harry Richford

In this post, Vanessa Cashman discusses this recent criminal prosecution regarding the failings in maternity care from East Kent Hospitals University NHS Foundation Trust. It is a landmark case, being the first time that the CQC has prosecuted an NHS Trust over failings in clinical care.

Brennan and others v (1) City of Bradford Metropolitan District Council (2) Leeds Teaching Hospitals NHS Trust [2021]: healthcare litigation and human rights

In this post, Megan Griffiths looks at the recent case of Brennan and others v (1) City of Bradford Metropolitan District Council (2) Leeds Teaching Hospitals NHS Trust [2021]1 WLUK 429, a very sad case concerning the decomposition of a woman's body in a hospital mortuary.

Essure sterilisation implant litigation: Product liability and clinical negligence post-Cumberlege

Charley Turton begins 2021 with a look ahead to the Essure sterilisation implant litigation, including in particular how it may be impacted by the damning Cumberlege review. What is Essure? Essure, a permanent, non-surgical birth control implant was approved by NICE and first marketed in the UK in 2009. A small coil made from polyester … Continue reading Essure sterilisation implant litigation: Product liability and clinical negligence post-Cumberlege

COVID 19 Vaccine – questions of safety and civil liability

The Medicines and Healthcare Regulatory Agency (“MHRA”) has given Pfizer-BioNTech’s COVID-19 mRNA Vaccine BNT162b2 temporary authorisation under regulation 174 of the Human Medicines Regulations 2012, which enables temporary authorisation to be granted in response to situations such as pandemics. In this blog, which is the first of a two-part series, Cressida Mawdesley-Thomas considers when there could be civil liability for an unlicensed vaccine. It also considers the conditions imposed by the MHRA for the granting of the temporary authorisation to Pfizer-BioNTech’s COVID-19 vaccine.